Categories: News

President Biden’s Requirement for Vaccines and Covid Testing Increase Opportunities for Insurance Verification Services

TUSTIN, Calif., Sept. 14, 2021 /PRNewswire/ — President Biden’s September 9th announcement to combat the Delta Variant triggered a change in American Business’ involvement in employees’ medical history, a move that expands the need to verify a patient’s medical records from medical providers and military/university to millions of employers.

Insurance Eligibility Verification Services, such as pVerify, provide accurate insurance benefit details for Medical Providers, Labs, and Suppliers. The need for medical information will expand outside of the Medical Community for the first time.  

According to the Associated Press the action plan “mandates vaccines for federal workers and contractors and certain health care workers, requires employees at companies with 100 or more workers to be vaccinated or tested weekly”, but leaves out the steps on how a business will comply.

Currently, only a Medical Provider or Healthcare Agency with a Registered National Provider Identifier (NPI) can look up a patient’s insurance coverage, according to the Department of Health and Human Services’  NPI Final Rule, and HIPAA restricts who can acquire a patient’s vaccination history.

The above restrictions may force businesses to pay out of pocket for services within the medical community with entities such as pVerify who have access to verification services, in order to accurately confirm a patient’s active insurance coverage, lab and testing benefits, and, for Medicare patients, Pfizer and Moderna vaccination dates.

It is unknown if Biden’s Action Plan is here to stay. “When this decree goes into effect, the (Republican National Committee) will sue the administration to protect Americans and their liberties,” RNC Chair Ronna McDaniel said in a statement. In the meantime businesses must continue mounting plans to track vaccinations or hire a laboratory group for the task of weekly testing.

pVerify, Inc‘s HIPAA-complaint, SaaS offering includes fully-customizable Eligibility Portal, robust set of REST APIs, and Mobile SDKs that power mission-critical, front-end Eligibility process solutions for leading software companies as well as ambulatory practices in the healthcare sector. pVerify is the leader in Healthcare Eligibility, with a focus on Surgical, Laboratory, Physical Therapy, Dermatology and Ophthalmology Eligibility.

pVerify® was founded in 2006 by a team of accomplished Healthcare Professionals with a singular focus: streamline the front-end patient insurance eligibility and benefit verification processes to not only maximize practice revenue but also minimize insurance denials.

Media Contact: Jessica ODaniel, pVerify, Inc.

Phone: 949-309-2850

Email: JODaniel@pVerify.com

View original content:https://www.prnewswire.com/news-releases/president-bidens-requirement-for-vaccines-and-covid-testing-increase-opportunities-for-insurance-verification-services-301376169.html

SOURCE pVerify, Inc.

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

6 hours ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

9 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

9 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

9 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

9 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

9 hours ago